Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PF3F | ISIN: US70465T1079 | Ticker-Symbol: EU6
Tradegate
27.03.24
20:27 Uhr
3,475 Euro
-0,160
-4,40 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PDS BIOTECHNOLOGY CORPORATION Chart 1 Jahr
5-Tage-Chart
PDS BIOTECHNOLOGY CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
3,5953,73010:30
3,5953,73010:15

Aktuelle News zur PDS BIOTECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:06Earnings call: PDS Biotech reports on clinical progress and financials1
MiPDS Biotechnology Corp reports results for the quarter ended in December - Earnings Summary4
MiPDS Biotechnology Corporation: PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results47Unique mechanism of action of the combination of PDS01ADC and Versamune® results in 3-year survival of 75% and 75% overall response rate in advanced head and neck cancer trial As a result, Company...
► Artikel lesen
MiPDS Biotechnology GAAP EPS of -$1.39 beats by $0.065
MiPDS Biotechnology Corp - 8-K, Current Report1
DiPDS Biotechnology FY 2023 Earnings Preview2
DiEarnings Preview For PDS Biotechnology2
20.03.PDS Biotechnology Corporation: PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results4
13.03.PDS Biotechnology Corporation: PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune85Preclinical research published in Vaccines demonstrates Infectimune® significantly improved quantity and quality of potent multifunctional CD4 T cells compared to vaccine adjuvants Patent for composition...
► Artikel lesen
13.03.PDS Biotechnology Corp - 8-K, Current Report1
19.02.PDS-01ADC by PDS Biotechnology for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval11
07.02.LFE's wholly owned subsidiary secures RM11 mil earthworks contract from PDSB4
23.01.PDS Biotech names Kirk V. Shepard as Chief Medical Officer3
22.01.PDS Biotechnology Corporation: PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer117PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or "the Company"), a clinical-stage immunotherapy company developing a growing pipeline...
► Artikel lesen
16.01.PDS Biotechnology Corporation: PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference1
04.12.23PDS Biotechnology Corporation: PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)236PRINCETON, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or "Company"), a clinical-stage immunotherapy company developing a growing pipeline of...
► Artikel lesen
28.11.23PDS Biotech appoints Lars Boesgaard as chief financial officer1
28.11.23PDS Biotechnology Appoints Lars Boesgaard To Succeed Matthew Hill As CFO-
28.11.23PDS Biotechnology Corporation: PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer473PRINCETON, N.J., Nov. 28, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a clinical-stage immunotherapy company developing a growing pipeline...
► Artikel lesen
28.11.23PDS Biotechnology Corp - 8-K, Current Report-
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1